Results from a new study suggest a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could help erase the need for insulin in folks with Type 2 diabetes. Photo by ...

Researchers engineered immune cells that protect insulin-producing cell transplants, bringing scientists closer to a cure for ...

Proof-of-concept trial in a single patient shows that cells can survive transplantation without immunosuppression ...

Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...

Chinese researchers report the first reversal of type 2 diabetes using stem cell therapy, restoring natural insulin ...

Early clinical trials established the safety and feasibility of closed-loop insulin delivery, but the 2019 iDCL trial1 marked the first large, outpatient, randomised, controlled trial to show a ...

A clinical trial has shown that Ozempic improves blood glucose levels and weight loss in overweight type 1 diabetics who use an automated insulin delivery system. It’s hoped that this will lead to the ...

Presentations on insulin therapy in type 2 diabetes from the 2023 annual meeting of the American Diabetes Association are presented by Dr Carol Wysham from the University of Washington School of ...

A comprehensive study presented at the Endocrine Society’s ENDO 24 annual meeting has revolutionized understanding of diabetes management during pregnancy. Following 10,117 mother-child pairs for up ...

Children and adolescents with diabetes using inhaled insulin had an increase in HbA1c from baseline to 1 year, according to data from the INHALE-1 extension trial published in Diabetes Technology & ...

MADRID — The de-escalation of a multiple daily injection regimen of insulin for type 2 diabetes to a once-daily fixed-ratio combination of insulin glargine U100 and glucagon-like peptide 1 receptor ...

Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...